Replies to post #94624 on Innovation Pharmaceuticals Inc (IPIX)

[BooDog]

without seeing the actual correspondence I'm not sure nasdaq is "vetting" anyone. Simply send Leo a list of questions to which they are addressing.

"In other corporate developments, Cellceutix is also pleased to inform shareholders that Nasdaq has responded to the Company with a "request for additional information" regarding Cellceutix's application to be listed on the Nasdaq exchange. Cellceutix executives and legal counsel are preparing the requisite information as requested as part of the move to uplist to Nasdaq."


havendale'

Agreed Tails, however in the world of conflict of interests, probably very minor and maybe that's why CTIX is letting NASDAQ vette board members (which I must admit, in my 30 years of stock investing, this is the first time I ever heard of an exchange vetting possible board members)

Compared to Ackman - Valeant/Allergan and others such as Randal Kirk, Chairman/CEO of Intrexon who is also on the board of directors of Ziopharm, and they have a partnership on a drug, and many, many others, to me, Shapiro being on CTIX's board is not aconflict considering where the trial is. And he could resign as lead investigator, once a board member, and let someone else be lead investigator to finish phase 1.

Like I said, unlikely, maybe, if it happens, the truck.

Best regards.

Agree with the Truck though, :-) every share I can. :-)

[TheMonolith]

CTIX up-listing has been a bit of saga. I hope it doesn't continue to be with a rejection. The board members thing is very strange, and maybe a protection of not building one if they don't end up getting up-listed.